1/47
Looks like no tags are added yet.
Learning Objectives
Describe disease states on sleep
Recommend non-pharmacological approaches for managing insomnia
Evaluate the efficacy and potential adverse effects of medications used to treat insomnia
Apply an insomnia treatment algorithm to select an appropriate agent based on patient characteristics
Explain the diagnostic and treatment principles for narcolepsy and restless legs syndrome
What sleep related disorders are discussed in this lecture?
Insomnia → Inability to initiate/maintain sleep
Narcolepsy → Excessive & uncontrollable daytime sleepiness
Restless Leg Syndrome (RLS)
Urge to move legs
Associated with unpleasant sensations
What are the four stages of sleep?
NREM 1
NREM 2
NREM 3
REM
What are good sleep habits to counsel patients on?
Regular bedtimes & awakenings
Go to bed when sleepy
Sleep long enough to avoid feeling tired, but no more
Optimize the bedroom conditions
Develop a bedtime ritual to unwind
Do not stay in bed more than 15–20 minutes when unable to sleep
Avoid eating, caffeine, exercise prior to bed
How is insomnia defined?
Inability to initiate or maintain sleep despite adequate time and opportunity for sleep
Falling asleep (sleep onset/initiation)
Staying asleep (sleep maintenance)
Nonrestorative sleep
Results in daytime impairment
What are factors related to insomnia?
Pain
Psychiatric disorders
Depression, anxiety
Substance abuse/use
Medications
SSRIs
Stimulants
Glucocorticoids
Opioids
How is cognitive behavioral therapy (CBT) used in insomnia?
Multicomponent approach
Sleep education and sleep hygiene advice
Stimulus control and sleep restriction
Cognitive psychotherapy
Which medications are used for insomnia?
Nonbenzodiazepine hypnotics
Also known as the “Z-hypnotics”
Melatonin receptor agonist
Orexin receptor antagonists (DORAs)
Benzodiazepines (BZD)
Antihistamines
Antidepressants*
Antipsychotics*
*off label
What is the MOA of nonbenzodiazepine hypnotics?
Bind selectively to the GABAA receptor and enhance the inhibitory action of GABA in the CNS
Binds to omega-1
Minimally to omega 2 & 3 benzodiazepine receptors
What are advantages of using nonbenzodiazepine hypnotics?
Less cognitive, memory and motor side effects
Shorter half-life
Less hangover effects
Less tolerance, addiction potential, withdrawal symptoms than with BZD
Which nonbenzodiazepine hypnotics are used?
Eszopiclone (Lunesta) → Onset + maintenance
Zaleplon (sonata) → Onset only
Zolpidem (Ambien) → Onset + maintenance
Zolpidem XR
Zolpidem fasting-acting (Intermezzo)
What are AEs associated with nonbenzodiazepine hypnotics?
Headache
Drowsiness
Dizziness
Severe allergic reaction (anaphylaxis and facial swelling)
Beer's list: BZD and Z-hypnotics → avoid in elderly
Unpleasant metallic taste with Eszopiclone
What rare warning is aassociated with nonbenzodiazepine hypnotics?
Somnambulism/confused behaviors (5%)
May occur w/ all prescription sleep meds
driving, talking on phone, eating
behaviors while under influence meds with no memory of the events
anterograde amnesia
more likely if used w/ EtOH
What kind of medication is Ramelteon (Rozerem)?
Melatonin Receptor agonist
What is Ramelteon’s MOA?
Melatonin receptor agonist in the suprachiasmatic nucleus (SCN)
SCN is located above optic chiasm in hypothalamus
Regulates sleep & circadian rhythm
High affinity for MT-1 and MT-2 receptors
MT-1 receptor regulates sleepiness
MT-2 receptor regulates circadian rhythm
What is Ramelteon’s (Rozerem) role in therapy?
Role in insomnia
Decrease sleep onset latency
Recommended for sleep-initiation
Not effective for sleep maintenance
No limitation on duration of use
No abuse liability, non-scheduled by DEA
No evidence of dependence or tolerance
What are AEs associated with Ramelteon (MRA)?
Well tolerated, even in the elderly
Dizziness, fatigue, rare cases of anaphylaxis & angioedema
Symptoms of hyperprolactinemia or reduced testosterone
How should Ramelteon be taken?
Take 30min before bedtime
Avoid hazardous activities after taking
Full benefits may take up to 3 weeks
Who should NOT take Ramelteon?
Avoid with hepatic impairment (moderate to severe)
May be considered in pts w/ substance abuse history
What are DORAs? What is their MOA and use in therapy?
Dual Orexin Receptor Antagonists (DORAs)
Orexin role
Hypothalamic neurotransmitter that stabilizes wakefulness and suppresses sleep-inducing pathways
DORAs MOA → Block orexin-1 and orexin-2 receptors (OX1R, OX2R) → reduce orexin signaling → promote sleep
FDA approved (C-IV ) for insomnia
What are benefits of using DORAs?
Decreased sleep latency
Increased sleep efficiency
Increased total sleep time
Which DORAs do we use?
Lemborexant (Dayvigo) — 5-10 mg
Suvorexant (Belsomra) — 10-20 mg
Daridorexant (Quviviq) — 25-50mg
All indicated for sleep onset/maintenance
What drug interactions do DORAs have?
Lemborexant → DIs with CYP3A4
Others have DI with CYP3A
What are benefits of using DORAs?
Not associated with tolerance, rebound insomnia, or withdrawal
Not on Beers criteria (can be considered in elderly-lowest dose)
but next day drowsiness is still an issue
What are AEs of using DORAs?
Somnolence: dose-dependent impairment in driving the morning after
Rare sleep paralysis & cataplexy-like symptoms
Abnormal dreams, dry mouth, fatigue
What is a contraindication of using DORAs?
Narcolepsy
Which sedative-hypnotic benzodiazepines are used in insomnia?
Estazolam → Used for sleep onset or maintenance of insomnia
Flurazepam → Sleep onset + insomnia
Tempazepam → Sleep onset + insomnia
Triazolam → Sleep onset only
What are issues of using BZDs for insomnia?
Tolerance
Works best for 2–4 weeks
Over time, may need higher doses for same effect
Dependence
Can develop with long-term use
Withdrawal symptoms: trouble sleeping, sensitivity to light/sound, tinnitus, rarely seizures
Residual daytime sedation
Rebound insomnia
Anterograde Amnesia
All BZDs appear to impair the acquisition and encoding of new information (anterograde amnesia) while under their influence
Caution when using benzodiazepines in the elderly
Can cause memory problems
Increase the risk of falls
Accumulate (w/ the long half-life drugs)
Which OTC products do we use as sleep aids?
1st Gen Antihistamines → crosses BBB into CNS and blocks H1 receptors causing drowsiness
Regular use is not recommended
To avoid rapid development of tolerance
Some data suggest that they do not maintain sedative efficacy beyond a few days to weeks
Associated with higher incidence of daytime sedation than short- or intermediate-acting BZDs
Who should we avoid Diphenhydramine use in?
Avoid in the elderly
Anticholinergic action can worsen cognitive function or other medical conditions (on Beers Criteria list)
Do not use with cholinesterase inhibitors used for Alzheimer’s disease
Diminution of desired therapeutic outcomes
What are potential adverse effects of Diphenhydramine?
Residual next-day sedation
Anticholinergic SEs
What is the role of sedating antidepressants in insomnia?
Often prescribed in absence of depression
Trazodone is common
Used more often for tx of insomnia than the FDA-approved hypnotics
Amitriptyline
Doxepin
Mirtazapine
Doxepin
Sedation from muscarinic and histaminic receptor blockade
Which antidepressant can be used to help patients stay asleep?
Doxepin (Silenor) → used for those who have trouble staying asleep
What is Trazodone’s role/use in insomnia?
Popular for managing insomnia due to SSRI antidepressant
Devoids abuse potential →
Usual dose required is lower than that used for depression
Can be effective for insomnia for a few days but
Efficacy has not been fully established through clinical trials
Some studies suggest similar efficacy compared to zolpidem during 1st week but comparable efficacy to placebo by the second week (due to tolerance)
What are antipsychotic med’s role in insomnia?
Not 1st-line and should only be used with appropriate indication (psychosis, agitation) but sometime prescribed off-label
Most commonly used are:
Quetiapine
Olanzapine
Sedation from muscarinic & histaminic receptor blockade
Why do/don’t we use antipsychotics?
Benefit/harm ratio is unfavorable
Weight gain, metabolic dysregulation, falls & cardiac mortality in elderly
Patient has diificulty FALLING asleep: What factors do we consider in the agent we choose?
If we want to avoid next-morning residual sedation with risk factors*
Ramelteon
*RFs = older age, cognitive dysfunction, opioid use
If avoiding next-morning residual sedation is NOT a priority:
DORA
Non-BZD hypnotics
Ramelteon
Patient has diificulty STAYING asleep: What factors do we consider in the agent we choose?
Patient has RFs (older age, cognitive dysfunction, opioid use)
DORAs
Doxepin (low-dose)
No RFs
DORA
Non-BZD hypnotics (eszopiclone, zolpidem)
Doxepin (low-dose)
What is narcolepsy? How is it diagnosed?
Excessive daytime sleepiness with irresistible “sleep attacks”
Some experience cataplexy (sudden loss of muscle tone triggered by emotions)
May have sleep paralysis and hallucinations
Diagnosis:
Clinical history + sleep studies
Mean sleep latency <8 minutes with ≥2 sleep-onset REM periods
What is the pathophysiology of narcolepsy?
Associated with loss of orexin in hypothalamus (neuropeptide that promotes wakefulness & suppress sleep-inducing neurons)
CSF shows undetectable/very low orexin levels
What is cataplexy in narcolepsy?
Sudden, transient episodes of muscle weakness or paralysis during wakefulness
Complete voluntary muscle loss
Triggered by strong emotions: laughter, excitement, anger, surprise
Instability in REM sleep regulation (due to loss of orexin signaling)
Lasts 1-2 min
Is there loss of consciousness in cataplexy?
No, unlike seizures, patients remain awake and aware during the episode
How do we treat narcolepsy?
Both preventive & pharmacologic
Take naps at regularly scheduled times throughout the day
Stimulants may be used (early in the day) to increase wakefulness
Modafinil/Armodafinil (1st-line)
amphetamines (2nd line)
What can be taken for cataplexy prophylaxis?
TCAs, Venlafaxine, or Duloxetine → Suppress REM sleep
Sodium oxybate
What is sodium oxybate?
Sodium salt of GHB, a naturally occurring CNS transmitter with sedative and anesthetic properties
C-III substance
Indicated for treatment of cataplexy or excessive daytime sleepiness
Formulations: oral solution & ER powder form
What is Oveporexton (Orzeyful)?
Indication: treatment of narcolepsy type 1 (narcolepsy with cataplexy) in adults.
Mechanism: Acts as an oral orexin receptor 2 agonist to restore missing orexin signaling in the brain.
Dosing: taken orally twice daily
What is restless leg syndrome?
The urge to move legs, often with uncomfortable sensations
Worse at rest or night, improves with movement
Etiology
Due to a dysfunction w/ dopamine in the brain’s basal ganglia circuits
Reduced CNS iron stores (treat w/ iron replacement)
Which medications can we use for restless leg syndrome?
Dopamine agonist: Ropinirole, Pramipexole
Gabapentinoids: Gabapentin, Pregabalin